Cytokine-induced expansion of human CD34+ stem/progenitor and CD34+CD41+ early megakaryocytic marrow cells cultured on normal osteoblasts

Stem Cells

Volumn 17, Issue 2, 1999, Pages 92-99

  Ahmed, N ^a   Khokher, M A ^a   Hassan, H T ^a  

^a UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

Author keywords

CD34; CD41; Interleukin; Osteoblast; Stem cell factor; Thrombopoietin

Indexed keywords

CD34 ANTIGEN; CYTOKINE; FIBRINOGEN RECEPTOR; INTERLEUKIN 11; INTERLEUKIN 3; STEM CELL FACTOR; THROMBOPOIETIN;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MEGAKARYOCYTE; MOUSE; NONHUMAN; OSTEOBLAST; THROMBOCYTOPENIA;

ANIMALIA;

EID: 0033015427     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.170092     Document Type: Article

References (45)

1. Hassan HT, Zander AR. Stem cell factor as a survival and growth factor in human normal and malignant hematopoiesis. Acta Haematol 1996;95:257-262.
2. Cheng SL, Yang JW, Rifas L et al. Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology 1994;134:277-286.
3. Grothos S, Graves SE, Ohta S et al. The STRO-1+ fraction of adult human bone marrow contains the osteogenic progenitors. Blood 1994;84:4164-4173.
4. Hassan HT, Gutensohn K, Zander AR et al. CD34 positive cell sorting and enrichment: applications in blood banking and transplantation. In: Recktenwald D, Radbruch A, eds. Cell Separation Methods and Applications. New York: Marcel Dekker, Inc., 1998:283-292.
5. + cells from human bone marrow. STEM CELLS 1997;15:368-377.
6. Lord BI. The architecture of bone marrow cell populations. Int J Cell Cloning 1990;8:317-331.
7. Owen ME, Friedenstein AJ. Stromal stem cells: marrow-derived osteogenic precursors. CIBA Found Symp 1988;136:42.
8. Bennet JH, Joyner CJ, Triffitt JT et al. Adipocyte cells cultured from marrow have osteogenic potential. J Cell Sci 1991;99:131-135.
9. Taichman RS, Emerson SG. Human osteoblasts support hematopoiesis through the production of G-CSF. J Exp Med 1994;179:1677-1682.
10. Ohtsuki T, Suzu S, Nagata N et al. A human osteoblastic cell line, MG-63, produces two molecular types of macrophage colony stimulating factor. Biochem Biophys Acta 1992;1136:297.
11. Ishimi Y, Miyaura C, Jin CH et al. Interleukin-6 is produced by osteoblasts and induces bone resorption. J Immunol 1990;145:3297-3303.
12. Gowen M, Chapman K, Littlewood A et al. Production of TNF by human osteoblasts is modulated by other cytokines but not by osteopetrotic hormones. Endocrinology 1990;126:1250.
13. Marusic A, Kalinowski J, Jastrzebski S et al. Production of leukemia inhibitory factor mRNA and protein by malignant and immortalized bone cells. J Bone Miner Res 1993;8:617.
14. Matsuzaki K, Udagawa N, Takahashi N et al. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. Biochem Biophys Res Commun 1998;246:199-204.
15. Chaudhary LR, Spelsberg TC, Riggs BL. Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1 and TNF-alpha: lack of regulation by 17 beta-estradiol. Endocrinology 1992;130:2528-2534.
16. + dendritic cells and tartrate-resistant acid phosphatase-positive osteoclast-like multinucleated giant cells from human monocytes. Blood 1996;88:4029-4039.
17. + progenitors. Br J Haematol 1997;96:64-69.
18. Quinn JM, Fujikawa Y, McGee JO et al. Rodent osteoblast-like cells support osteoclastic differentiation of human cord blood monocytes in the presence of M-CSF and 1,25 dihydroxyvitamin D3. Int J Biochem Cell Biol 1997;29:173-179.
19. Sarma U, Flanagan AM. Macrophage colony stimulating factor induces substantial osteoclast generation and bone resorption in human bone marrow cultures. Blood 1996;88:2531-2540.
20. Nakagawa T, Nagata N, Hosaka N et al. Prevention of autoimmune inflammatory polyarthritis in male New Zealand black/KN mice by transplantation of bone marrow cells plus bone (stromal cells). Arthritis Rheum 1993;36:263-268.
21. Ishida T, Inaba M, Hisha H et al. Requirements of donor-derived stromal cells for successful allogeneic BMT: complete prevention of recurrence of autoimmune disease in MRL/MP-1pr/1pr mice by transplantation of bone marrow plus bones (stroma cells) from the same donor. J Immunol 1993;152:3119-3124.
22. Hisha H, Nishino T, Kawamura M et al Successful bone marrow transplantation by bone grafts in chimeric-resistant combination. Exp Hematol 1995;23:347-352.
23. El-Badri NS, Wang B-Y, Good CRA. Osteoblasts promote engraftment of allogeneic hematopoietic stem cells. Exp Hematol 1998;26:110-116.
24. Kruger W, Stockschlader M, Hassan HT et al. Purging in bone marrow and stem cell transplantation. J Lab Med 1996;20:210-220.
25. Hassan HT, Zander AR. Thrombocytopenia after high-dose chemotherapy and autologous stem cell transplantation: an unresolved problem and possible approaches to resolve it. J Hematother 1996;5:407-414.
26. Taichman RS, Reilly MJ, Emerson SG. Human osteoblasts support human hematopoietic progenitor cells in in vitro bone marrow cultures. Blood 1996;87:518-524.
27. + hematopoietic bone marrow cells in vitro. Blood 1997;89:1165-1172.
28. Hassan HT, Freund M. Characteristic biological features of human megakaryoblastic leukaemia cell lines. Leuk Res 1995;19:589-594.
29. Hassan HT, Krog C, Stockschlader M et al. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: A single-centre experience. Support Care Cancer 1997;5:299-306.
30. Guest JF, Munro V, Cookson RF. The annual cost of blood transfusions in the United Kingdom. Clin Lab Haematol 1998;20:111-118.
31. Khokher MA, Dandona P. The effect of diphosphonates on human osteoblasts in tissue culture. Metabolism 1989;38:184-187.
32. + cell selection. STEM CELLS 1996;14:419-429.
33. 3H) thymidine incorporation and alkaline phosphatase production by human osteoblasts. Metabolism 1990;39:1118-1121.
34. Hassan HT, Biermann B, Zander AR. Maintenance and expansion of erythropoiesis in human long-term bone marrow cultures in presence of erythropoietin plus stem cell factor and interleukin-3 or interleukin-11. Eur Cytokine Netw 1996;7:129-136.
35. Hassan HT, Stockschlader M, Schleimer B. Comparison of the content and subpopulations of CD3 and CD34 positive cells in bone marrow harvests and G-CSF-mobilised peripheral blood leukapheresis products from healthy adult donors. Transplant Immunol 1996;5:319-323.
36. Hassan HT, Zander AR. Human normal and leukaemic megakaryocytopoiesis. Cancer J 1995;8:170-172.
37. + cells have similar potential for ex-vivo expansion as primitive LTC-ICs in steady state bone marrow. Blood 1997;89:3991-3997.
38. + cells in allografts. Exp Hematol 1996;24:1072-1073.
39. + cells in cord blood in comparison with G-CSF-mobilized peripheral blood. Blood 1996;88(suppl 1):446.
40. - bone marrow cells with multipotential at the single cell level: key role of thrombopoietin. Blood 1997;90:2282-2292.
41. Ratajczak MZ, Ratajczak J, Machalinski B et al. In vitro and in vivo evidence that ex-vivo cytokine priming of donor marrow cells may ameliorate post-transplant thrombocytopenia. Blood 1998;91:353-359.
42. Williams JL, Pipia GG, Datta NS et al. Thrombopoietin requires additional megakaryocyte-acting cytokines for optimal ex-vivo expansion of megakaryocyte precursor cells. Blood 1998;91:4118-4126.
43. Schattner M, Lefebvre P, Mingolelli SS et al. Thrombopoietin-stimulated ex vivo expansion of human bone marrow megakaryocytes. STEM CELLS 1996;14:207-214.
44. Fibbe WE, Heemskerk DPM, Laterveer L et al. Accelerated reconstitution of platelets and erythrocytes after syngeneic transplantation of BM cells derived from thrombopoietin-treated donor mice. Blood 1995;86:3308-3313.
45. Bertolino F, Battaglia M, Pedrazzoli P et al. Megakaryocytic progenitors can be generated ex vivo and safely administered to aulologous peripheral blood progenitor cell transplant recipients. Blood 1997;89:2679-2688.